Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,472 | 7,422 | -13,599 | -10,030 | -5,114 |
| Depreciation Amortization | 65 | 422 | 317 | 206 | 103 |
| Accounts receivable | 151 | 194 | 432 | 664 | -717 |
| Accounts payable and accrued liabilities | -142 | 166 | -466 | -1,772 | -1,501 |
| Other Working Capital | -1,708 | -21,251 | -5,092 | -3,600 | -1,831 |
| Other Operating Activity | 408 | 8,161 | 6,212 | 4,857 | 1,832 |
| Operating Cash Flow | $-3,698 | $-4,886 | $-12,196 | $-9,675 | $-7,228 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 11,870 | 11,872 | 7,103 | 1,482 |
| PPE Investments | -38 | -196 | 150 | -389 | -387 |
| Other Investing Activity | 0 | 151 | -686 | 152 | 0 |
| Investing Cash Flow | $-38 | $11,825 | $11,336 | $6,866 | $1,095 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -78 | -56 | -30 |
| Other Financing Activity | 0 | -93 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $-93 | $-78 | $-56 | $-30 |
| Exchange Rate Effect | N/A | 285 | 281 | 211 | 13 |
| Beginning Cash Position | 19,166 | 12,035 | 12,035 | 12,035 | 12,035 |
| End Cash Position | 15,430 | 19,166 | 11,378 | 9,381 | 5,885 |
| Net Cash Flow | $-3,736 | $7,131 | $-657 | $-2,654 | $-6,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,698 | -4,886 | -12,196 | -9,675 | -7,228 |
| Capital Expenditure | -38 | -744 | 150 | -389 | -387 |
| Free Cash Flow | -3,736 | -5,630 | -12,046 | -10,064 | -7,615 |